These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9251875)

  • 1. Oral and subcutaneous sumatriptan in the acute treatment of migraine: an open randomized cross-over study.
    Carpay HA; Matthijsse P; Steinbuch M; Mulder PG
    Cephalalgia; 1997 Aug; 17(5):591-5. PubMed ID: 9251875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
    Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of sumatriptan in the treatment of multiple migraine attacks.
    Bussone G; Manzoni GC; Cortelli P; Roncolato M; Fabbri L; Benassuti C
    Neurol Sci; 2000 Oct; 21(5):272-8. PubMed ID: 11286039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat.
    Tfelt-Hansen P
    Cephalalgia; 1998 Oct; 18(8):532-8. PubMed ID: 9827244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group.
    Bousser MG; D'Allens H; Richard A
    J Intern Med; 1993 Aug; 234(2):211-6. PubMed ID: 8393474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies.
    Ryan R; Elkind A; Baker CC; Mullican W; DeBussey S; Asgharnejad M
    Neurology; 1997 Nov; 49(5):1225-30. PubMed ID: 9371898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A within-patient comparison of subcutaneous and oral sumatriptan in the acute treatment of migraine in general practice.
    Gruffydd-Jones K; Hood CA; Price DB
    Cephalalgia; 1997 Feb; 17(1):31-6. PubMed ID: 9051333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial.
    Schulman EA; Cady RK; Henry D; Batenhorst AS; Putnam DG; Watson CB; O'Quinn SO
    Mayo Clin Proc; 2000 Aug; 75(8):782-9. PubMed ID: 10943230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of subcutaneous sumatriptan using a novel self-injector.
    Gross ML; Kay J; Turner AM; Jewsbury J; Cleal AL
    Headache; 1995; 35(10):601-6. PubMed ID: 8550361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine.
    Pascual J; Bussone G; Hernandez JF; Allen C; Vrijens F; Patel K;
    Eur Neurol; 2001; 45(4):275-83. PubMed ID: 11385269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
    Winner P; Ricalde O; Le Force B; Saper J; Margul B
    Arch Neurol; 1996 Feb; 53(2):180-4. PubMed ID: 8639069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sumatriptan-nonresponders: a survey in 366 migraine patients.
    Visser WH; de Vriend RH; Jaspers NH; Ferrari MD
    Headache; 1996 Sep; 36(8):471-5. PubMed ID: 8824001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine.
    Nett R; Landy S; Shackelford S; Richardson MS; Ames M; Lener M
    Obstet Gynecol; 2003 Oct; 102(4):835-42. PubMed ID: 14551015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. The Sumatriptan Menstrual Migraine Study Group.
    Facchinetti F; Bonellie G; Kangasniemi P; Pascual J; Shuaib A
    Obstet Gynecol; 1995 Dec; 86(6):911-6. PubMed ID: 7501338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open-label study to assess changes in efficacy and satisfaction with migraine care when patients have access to multiple sumatriptan succinate formulations.
    Weidmann E; Unger J; Blair S; Friesen C; Hart C; Cady R
    Clin Ther; 2003 Jan; 25(1):235-46. PubMed ID: 12637123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience.
    Wilkinson M; Pfaffenrath V; Schoenen J; Diener HC; Steiner TJ
    Cephalalgia; 1995 Oct; 15(5):337-57. PubMed ID: 8536293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.